Clause 7.10

What this clause covers

Covers specific requirements around comparative claims and references. Where materials compare a product to a competitor or to standard of care, the comparison must be based on relevant, up-to-date evidence and must not create a misleading impression.

PMCPA Cases — Clause 7.10

52 cases

📅 8 Mar 2026 · AstraZeneca

AstraZeneca voluntary admission: uncertified Crestor promotional email with misleading dosing and comparative claims

Clause 14.1 Clause 3.2 Clause 4.1 Clause 7.10 +4 more

↗

📅 8 Mar 2026 · Roche Products

Novartis v Roche: Bondronat leavepiece—misleading indirect comparisons and renal safety messaging (AUTH/2199/1/09)

Clause 7.10 Clause 7.2 Clause 7.3 Clause 7.4 +2 more

↗

📅 8 Mar 2026 · Roche Products

AUTH/2191/12/08: Roche misleading comparative and “cost-effective” claims in Bondronat hospital detail aid (Novartis complaint)

Clause 7.10 Clause 7.2 Clause 7.3 Clause 7.4 +2 more

↗

🔒

See all 52 cases for Clause 7.10

Case Library members get full access to every PMCPA ruling, searchable by clause, company, outcome, and sanction.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

Already a member? Sign in

PMCPA Cases — Clause 7.10

AstraZeneca voluntary admission: uncertified Crestor promotional email with misleading dosing and comparative claims

Novartis v Roche: Bondronat leavepiece—misleading indirect comparisons and renal safety messaging (AUTH/2199/1/09)

AUTH/2191/12/08: Roche misleading comparative and “cost-effective” claims in Bondronat hospital detail aid (Novartis complaint)

See all 52 cases for Clause 7.10

📰 Weekly PMCPA Case Breakdown